COLLPLANT BIOTECHNOLOGIES LT (CLGN) Forecast, Price Target & Analyst Ratings

NASDAQ:CLGN • IL0004960188

Current stock price

0.6098 USD
+0.02 (+4.24%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for COLLPLANT BIOTECHNOLOGIES LT (CLGN).

Forecast Snapshot

Consensus Price Target

Price Target
$11.22
+ 1,739.95% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Estimate
-$0.19
Revenue Estimate
1.555M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
80.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$11.22
Upside
+ 1,739.95%
From current price of $0.61 to mean target of $11.22, Based on 8 analyst forecasts
Low
$11.11
Median
$11.22
High
$11.55

Price Target Revisions

1 Month
-4.35%
3 Months
-4.35%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for CLGN. The average price target is 11.22 USD. This implies a price increase of 1739.95% is expected in the next year compared to the current price of 0.6098.
The average price target has been revised downward by 4.35% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

CLGN Current Analyst RatingCLGN Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

CLGN Historical Analyst RatingsCLGN Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
80.00%
CLGN was analyzed by 8 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CLGN.
In the previous month the buy percentage consensus was at a similar level.
CLGN was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2026-02-06D. Boral CapitalDowngrade Buy -> Hold
2025-11-28D. Boral CapitalMaintains Buy -> Buy
2025-10-20D. Boral CapitalMaintains Buy -> Buy
2025-09-16D. Boral CapitalMaintains Buy -> Buy
2025-08-21HC Wainwright & Co.Reiterate Buy -> Buy
2025-08-20D. Boral CapitalMaintains Buy -> Buy
2025-05-30D. Boral CapitalMaintains Buy -> Buy
2025-05-28D. Boral CapitalMaintains Buy -> Buy
2025-03-27D. Boral CapitalMaintains Buy -> Buy
2025-02-12D. Boral CapitalMaintains Buy -> Buy
2025-02-04D. Boral CapitalMaintains Buy -> Buy
2024-11-29HC Wainwright & Co.Reiterate Buy -> Buy
2024-11-27D. Boral CapitalMaintains Buy -> Buy
2024-08-21HC Wainwright & Co.Reiterate Buy -> Buy
2024-08-20EF HuttonMaintains Buy -> Buy
2024-08-05EF HuttonInitiate Buy
2024-05-30HC Wainwright & Co.Reiterate Buy -> Buy
2024-04-05HC Wainwright & Co.Reiterate Buy -> Buy
2023-11-30HC Wainwright & Co.Reiterate Buy -> Buy
2023-08-25HC Wainwright & Co.Reiterate Buy -> Buy
2023-03-30HC Wainwright & Co.Maintains Buy
2023-02-17Alliance Global PartnersInitiate Buy
2021-02-09HC Wainwright & Co.Maintains Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 26, 2026
Period
Q4 / 2025
EPS Estimate
-$0.19
Revenue Estimate
1.555M
Revenue Q2Q
848.17%
EPS Q2Q
43.00%
Number of Analysts
4

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
-58.33%
EPS (3 Months)
-58.33%

Next Earnings Summary

CLGN is expected to report earnings on 3/26/2026. The consensus EPS estimate for the next earnings is -0.19 USD and the consensus revenue estimate is 1.55M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
CLGN revenue by date.CLGN revenue by date.
300K
-98.08%		10.959M
3,553.00%		515K
-95.30%		8.735M
1,596.12%		8.072M
-7.59%		11.142M
38.03%
EBITDA
YoY % growth
CLGN ebitda by date.CLGN ebitda by date.
-15.72M
-1,399.17%		-5.544M
64.73%		-15.927M
-187.28%		N/AN/AN/A
EBIT
YoY % growth
CLGN ebit by date.CLGN ebit by date.
-16.8M
-3,918.18%		-6.646M
60.44%		-16.965M
-155.27%		-7.094M
58.19%		-8.629M
-21.65%		-6.275M
27.28%
Operating Margin
CLGN operating margin by date.CLGN operating margin by date.
-5,600.00%-60.64%-3,294.17%-81.21%-106.90%-56.32%
EPS
YoY % growth
CLGN eps by date.CLGN eps by date.
-1.53
-15,200.00%		-0.46
69.93%		-1.46
-217.39%		-0.55
62.27%		-0.42
23.15%		-0.03
92.77%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.19
43.00%		-0.24
-88.31%		0.36
227.50%		-0.20
24.44%		-0.16
15.79%
Revenue
Q2Q % growth		1.555M
848.17%		795.6K
-61.28%		9.996M
5,484.36%		1.224M
1,489.61%		1.836M
18.07%
EBITDA
Q2Q % growth		N/AN/AN/AN/AN/A
EBIT
Q2Q % growth		-3.511M
11.65%		-3.796M
-130.37%		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

CLGN Yearly Revenue VS EstimatesCLGN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5M 10M 15M
CLGN Yearly EPS VS EstimatesCLGN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.5 -1 -1.5

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
25.55%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
88.14%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

COLLPLANT BIOTECHNOLOGIES LT / CLGN Forecast FAQ

Can you provide the average price target for COLLPLANT BIOTECHNOLOGIES LT stock?

8 analysts have analysed CLGN and the average price target is 11.22 USD. This implies a price increase of 1739.95% is expected in the next year compared to the current price of 0.6098.

What is the next earnings date for CLGN stock?

COLLPLANT BIOTECHNOLOGIES LT (CLGN) will report earnings on 2026-03-26, before the market open.

Can you provide the consensus estimates for COLLPLANT BIOTECHNOLOGIES LT next earnings?

The consensus EPS estimate for the next earnings of COLLPLANT BIOTECHNOLOGIES LT (CLGN) is -0.19 USD and the consensus revenue estimate is 1.55M USD.

Can you provide the expected long term growth rate for COLLPLANT BIOTECHNOLOGIES LT stock?

The expected long term growth rate for COLLPLANT BIOTECHNOLOGIES LT (CLGN) is 88.14%.